CIK 0001756262
- Large accelerated filer
TransMedics Group, Inc.
Sign in to watch- Ticker
- TMDX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- Phone
- +1 978-552-0900
- Business address
- 200 MINUTEMAN ROAD, ANDOVER, MA, 01810
- Open-market buys, last 90 days
- $109,058
- in 1 filing
- Open-market sales, last 90 days
- $385,464
- in 1 filing
Net −$276,406. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 31 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-05 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +14,548 | $0.39 | $6K | 60,624 |
| 2021-03-05 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion | +5,452 | $0.28 | $2K | 66,076 |
| 2021-03-05 | Khayal Tamer I Chief Commercial Officer | Sale | −5,783 | $30.45 | $176K | 60,293 |
| 2021-03-05 | Khayal Tamer I Chief Commercial Officer | Sale | −14,217 | $31.09 | $442K | 46,076 |
| 2021-03-05 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −14,548 | 0 | ||
| 2021-03-05 | Khayal Tamer I Chief Commercial Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,452 | 52,177 | ||
| 2021-02-24 | Gordon Stephen Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2021-02-24 | Hassanein Waleed H President & CEO | Grant or award · Stock Option (Right to Buy) | +310,000 | 310,000 | ||
| 2021-02-24 | Carey John F VP of Operations | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-02-24 | Sullivan John F VP of Quality & Engineering | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-02-24 | Khayal Tamer I Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2021-02-24 | Provost Miriam VP of US Regulatory & FDA Rel. | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-02-24 | DAMME LAURA VP, Clinical Affairs | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-02-16 | Gordon Stephen Chief Financial Officer | Exercise or conversion | +10,000 | $0.67 | $7K | 10,000 |
| 2021-02-16 | Gordon Stephen Chief Financial Officer | Sale | −10,000 | $31.33 | $313K | 0 |
| 2021-02-16 | Gordon Stephen Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,000 | 45,713 | ||
| 2021-02-09 | Sullivan John F VP of Quality & Engineering | Exercise or conversion | +8,600 | $0.28 | $2K | 19,428 |
| 2021-02-09 | Sullivan John F VP of Quality & Engineering | Sale | −8,400 | $32.78 | $275K | 11,028 |
| 2021-02-09 | Sullivan John F VP of Quality & Engineering | Sale | −200 | $34.18 | $7K | 10,828 |
| 2021-02-09 | Sullivan John F VP of Quality & Engineering | Exercise or conversion · Stock Option (Right to Buy) | +8,600 | 0 |
Page 46 of 49 · 980 trades